Assessment of Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment for the Anti-Staphylococcal Antibiotic Afabicin

David R. Cameron 1, Justine Dao 1, Christopher M. Rubino 2, Annick Menetrey 1, Anthony P. Cammarata 2, Jeffrey P. Hammel 2, Guennaelle Dieppois 1, Justyna Nowakowska 1, Juan Bravo 1, Brian D. VanScoy 2, Stephen Hawser 3, Valerie Nicolas-Metral 1, Sujata M. Bhavnani 2   ​

1) Debiopharm International SA, Lausanne, Switzerland;
2) Institute for Clinical Pharmacodynamics, Schenectady, New York, United States;
3) IHMA Europe, Monthey, Switzerland​